Caribou Biosciences, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Berkeley, CA
CRBU chart
What traders are saying about $CRBU
Latest postsCaribou Biosciences, Inc. news
- Weekly Recap: Q3 financial results and strategic alternatives review
TradingView ·
- Caribou Biosciences Stock Price Forecast. Should You Buy CRBU?
StockInvest.us ·
- Caribou Biosciences earnings beat by $0.02, revenue fell short of estimates
Investing.com ·
- Caribou Biosciences : Quarterly Report for Quarter Ending September 30, 2026 (Form 10-Q)
www.marketscreener.com ·
- Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Beats Revenue Estimates
Yahoo Finance ·
- Caribou Biosciences Q3 revenue declines, to discontinue lead clinical program
TradingView ·
- Castle Biosciences, Inc. (CSTL) Reports Q3 Loss, Beats Revenue Estimates
Yahoo Finance ·
- Caribou Biosciences Reports Q3 2026 Net Loss of $26.6 Million
TradingView ·
- Liquidation is among the options as Caribou Biosciences (CRBU) plans to halt two drug programs.
Stock Titan ·
- Caribou Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
www.marketscreener.com ·
- Press Release: Caribou Biosciences Reports Third Quarter 2026 Financial Results
Moomoo ·
- CARIBOU BIOSCIENCES Q3 BASIC EPS USD -0.25
Moomoo ·
Caribou Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $11.2M | $10.0M | $34.5M | $13.9M |
| Net income | -$148.1M | -$149.1M | -$102.1M | -$99.4M |
| Diluted EPS | $-1.59 | $-1.65 | $-1.38 | $-1.64 |
| Total assets (year end) | $175.4M | $313.3M | $432.2M | $373.8M |
| Cash and equivalents (year end) | $12.4M | $16.3M | $51.2M | $58.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Caribou Biosciences, Inc.
- Ticker
- CRBU (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Berkeley, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1619856
Frequently asked questions
What exchange is Caribou Biosciences, Inc. listed on?
Caribou Biosciences, Inc. trades on the Nasdaq under the ticker symbol CRBU.
What industry is Caribou Biosciences, Inc. in?
Caribou Biosciences, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Caribou Biosciences, Inc. headquartered?
Caribou Biosciences, Inc.'s business address on file with the SEC is in Berkeley, CA.
When does Caribou Biosciences, Inc.'s fiscal year end?
Caribou Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Caribou Biosciences, Inc. report?
Caribou Biosciences, Inc. reported $11.2M in revenue for calendar year 2025, according to its SEC filings.